The ESPR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ESPR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ESPR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View ESPR Detailed Price Forecast - CNN Money | View ESPR Detailed Summary - Google Finance | ||
View ESPR Detailed Summary - Yahoo! Finance | View ESPR Stock Research & Analysis - Zacks.com |
View ESPR Trends & Analysis - Trade-Ideas | View ESPR Major Holders - Barrons | ||
View ESPR Call Transcripts - NASDAQ | View ESPR Breaking News & Analysis - Seeking Alpha | ||
View ESPR Annual Report - CompanySpotlight.com | View ESPR OTC Short Report - OTCShortReport.com | ||
View ESPR Fundamentals - TradeKing | View ESPR SEC Filings - Bar Chart | ||
View Historical Prices for ESPR - The WSJ | View Performance/Total Return for ESPR - Morningstar | ||
View the Analyst Estimates for ESPR - MarketWatch | View the Earnings History for ESPR - CNBC | ||
View the ESPR Earnings - StockMarketWatch | View ESPR Buy or Sell Recommendations - MacroAxis | ||
View the ESPR Bullish Patterns - American Bulls | View ESPR Short Pain Metrics - ShortPainBot.com |
View ESPR Stock Mentions - StockTwits | View ESPR Stock Mentions - PennyStockTweets | ||
View ESPR Stock Mentions - Twitter | View ESPR Investment Forum News - Investor Hub | ||
View ESPR Stock Mentions - Yahoo! Message Board | View ESPR Stock Mentions - Seeking Alpha |
View Insider Transactions for ESPR - SECform4.com | View Insider Transactions for ESPR - Insider Cow | ||
View ESPR Major Holdings Summary - CNBC | View Insider Disclosure for ESPR - OTC Markets | ||
View Insider Transactions for ESPR - Yahoo! Finance | View Institutional Holdings for ESPR - NASDAQ |
View ESPR Stock Insight & Charts - FinViz.com | View ESPR Investment Charts - StockCharts.com | ||
View ESPR Stock Overview & Charts - BarChart | View ESPR User Generated Charts - Trading View |
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Posted on Thursday April 25, 2024
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Esperion to Report First Quarter 2024 Financial Results on May 7
Posted on Tuesday April 23, 2024
ANN ARBOR, Mich., April 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. Please click here to pre-register to participate in the conference call and obtain your dial in number and PIN. A live audio webcast can be accessed on the investor and me
11 Best Low Price Pharma Stocks To Invest In
Posted on Sunday April 21, 2024
In this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want to skip to the five top low price stocks in this list, then you can skip ahead to 5 Best Low Price Pharma […]
Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity
Posted on Sunday April 07, 2024
– Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to Placebo – – NEXLETOL Demonstrated Clinical Benefit in Historically Underrepresented Groups: Women and Hispanic/Latinx Patients With and Without Cardiovascular Disease (CVD) – – CLEAR Outcomes Sets New Standards for Diversity and Inclusion with Enrollment of 48% Women and 17% Hispanic/Latinx Patients – ANN ARBOR, Mich., April 07, 2024 (GLOBE NEWSWIRE) -- Esperion